Correlation of c-Met Expression and Outcome in Patients With Renal Cell Carcinoma Treated With Sunitinib

High c-Met expression was associated with poor survival in patients with mRCC treated with sunitinib. Interestingly, the prognostic role may vary based on the location of metastases.